Waltham, MA, United States of America

Sheila Irene Hauck

USPTO Granted Patents = 14 


 

Average Co-Inventor Count = 4.8

ph-index = 5

Forward Citations = 91(Granted Patents)


Location History:

  • Waltham, MA (US) (2007 - 2015)
  • Lincoln, MA (US) (2017 - 2023)

Company Filing History:


Years Active: 2007-2023

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Sheila Irene Hauck

Introduction

Sheila Irene Hauck is a prominent inventor based in Waltham, MA (US), known for her significant contributions to the field of proteostasis. With a remarkable portfolio of 14 patents, she has made strides in developing compounds that enhance proteasome activity, which is crucial for maintaining cellular health.

Latest Patents

Among her latest patents, Hauck has focused on proteasome activity enhancing compounds. One of her inventions is directed to compounds that inhibit Usp14, along with compositions and methods for treating conditions associated with dysfunction in proteostasis. Another patent involves compounds with specific formulas that also aim to enhance proteasome activity and address related health issues.

Career Highlights

Throughout her career, Sheila has worked with notable companies such as AstraZeneca and Proteostasis Therapeutics, Inc. Her work in these organizations has allowed her to apply her innovative ideas in practical settings, contributing to advancements in therapeutic solutions.

Collaborations

Sheila has collaborated with esteemed colleagues, including Gregory Steven Basarab and Fei Zhou. These partnerships have fostered a collaborative environment that enhances the development of her innovative projects.

Conclusion

Sheila Irene Hauck's contributions to the field of proteostasis through her patents and collaborations highlight her role as a leading inventor. Her work continues to impact the scientific community and offers promising avenues for future research and development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…